Zydus Life shares rise 2% after USFDA nod for Eluxadoline tablets - MSN
14 hours ago • Google News
Zydus Lifesciences Limited (ZYDUSLIFE)
NSEINR 917.250.81%
Price Chart
Key Statistics
Market Cap
INR 915.57B
P/E Ratio
20.20
Revenue (TTM)
INR 222.47B
Volume
689.23K
52W High
INR 1324.30
52W Low
INR 855.10
Dividend Yield
0.33%
Beta
0.47
Technicals
50-Day MA
936.696
200-Day MA
1037.092
52 Week High
1324.3
52 Week Low
855.1
About ZYDUSLIFE
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates .
Employees
26921
Headquarters
Ahmedabad, India
CEO
Dr. Sharvil Pankajbhai Patel
Latest News
Zydus Life shares rise 2% after USFDA nod for Eluxadoline tablets - The Economic Times
3 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg